Publications by authors named "W-J Zhou"

Article Synopsis
  • The study focuses on a dual-layer polycaprolactone (PCL) scaffold designed to enhance soft tissue repair in oral mucosal defects.
  • The scaffolds feature different fiber patterns (parallel, rhombic, square) and showed improved properties like surface wettability and tensile strength compared to disordered scaffolds.
  • Notably, the square-patterned scaffold promoted cell differentiation and accelerated wound healing, suggesting strong potential for clinical applications in a bacteria-prone oral environment.
View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) is a significant health challenge with limited treatments, and YangXue QingNao Wan (YXQNW) is a TCM formula being tested for its effectiveness against AD in clinical trials.
  • This study investigates the anti-AD properties of YXQNW through an innovative endophenotype network strategy, identifying active ingredients and clarifying their therapeutic mechanisms.
  • Results show a strong correlation between YXQNW's effects and amyloid β levels, indicating its potential role in addressing AD's pathology.
View Article and Find Full Text PDF
Article Synopsis
  • Small interfering RNAs (siRNAs) have the potential to target and silence difficult disease-related genes, providing new ways to treat diseases.* -
  • While delivering siRNAs to the liver via N-acetylgalactosamine (GalNAc) has proven effective, delivering siRNAs to other cell types remains a challenge.* -
  • Research shows that certain cellular mechanisms, including retrograde transport and lipid droplets, can enhance the effectiveness of siRNA delivery and gene silencing in both liver and non-liver cell types.*
View Article and Find Full Text PDF
Article Synopsis
  • Biallelic loss of CDK12 is linked to a specific subtype of metastatic castration-resistant prostate cancer (mCRPC), raising questions about its role in cancer development versus exposing drug targets.
  • Research shows that loss of CDK12 leads to early cancer-like changes and enhances cancer cell growth when combined with mutations in other genes like Trp53, while it inhibits tumor growth in the absence of another tumor suppressor gene, Pten.
  • CDK12 loss causes genomic instability and makes tumors sensitive to treatments targeting another protein, CDK13, highlighting CDK12 as a crucial tumor suppressor and suggesting new therapeutic approaches for CDK12-mutant mCRPC.
View Article and Find Full Text PDF

bacteria are enriched on poly(ethylene terephthalate) (PET) microplastics in wastewaters and urban rivers, but the PET-degrading mechanisms remain unclear. Here, we investigated these mechanisms with KF-1, a wastewater isolate, by combining microscopy, spectroscopy, proteomics, protein modeling, and genetic engineering. Compared to minor dents on PET films, scanning electron microscopy revealed significant fragmentation of PET pellets, resulting in a 3.

View Article and Find Full Text PDF

Cyclin-dependent kinases 12/13 play pivotal roles in orchestrating transcription elongation, DNA damage response, and maintenance of genomic stability. Biallelic CDK12 loss has been documented in various malignancies. Here, we develop a selective CDK12/13 PROTAC degrader, YJ9069, which effectively inhibits proliferation in subsets of prostate cancer cells preferentially over benign immortalized cells.

View Article and Find Full Text PDF
Article Synopsis
  • Complex structural variations (cxSVs) are often missed in genome studies due to difficulties in detection, but ARC-SV provides a machine-learning method to accurately identify and reconstruct them from standard genetic datasets.
  • * Our research identified cxSVs as key contributors to human genetic diversity, showing that rare cxSVs frequently occur in genes related to neural functions and rapid human evolution.
  • * Through advanced analysis of brain tissue, we found cxSVs are linked to gene expression changes and are associated with psychiatric disorders, suggesting they play a significant role in the development of neuropsychiatric conditions.
View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment of infants hospitalized with RSV infection.

Methods: In a phase 3, multicenter, double-blind, randomized, placebo-controlled trial conducted in China, we enrolled participants 1 to 24 months of age who were hospitalized with RSV infection.

View Article and Find Full Text PDF

The ALPINE trial established the superiority of zanubrutinib over ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma; here, we present data from the final comparative analysis with extended follow-up. Overall, 652 patients received zanubrutinib (n = 327) or ibrutinib (n = 325). At an overall median follow-up of 42.

View Article and Find Full Text PDF

Background: The long-term impact of drug-coated balloon (DCB) angioplasty for the treatment of patients with de novo coronary artery lesions remains uncertain. We aimed to assess the non-inferiority of DCB angioplasty with rescue stenting to intended drug-eluting stent (DES) deployment for patients with de novo, non-complex coronary artery lesions.

Methods: REC-CAGEFREE I was an open-label, randomised, non-inferiority trial conducted at 43 sites in China.

View Article and Find Full Text PDF

Introduction: Despite increasing studies confirming the efficacy of vedolizumab (VDZ) in Crohn's disease (CD), improving the responses to this biologic agent remains challenging in clinical practice. In this article, we investigated the efficacy of combined treatment of VDZ and 16-week exclusive enteral nutrition (EEN) in moderately to severely active CD.

Methods: From October 2020 to October 2023, 81 patients with moderately to severely active CD treated with VDZ from 2 inflammatory bowel disease centers were retrospectively selected.

View Article and Find Full Text PDF
Article Synopsis
  • The evolution of SARS-CoV-2 variants highlights the need for multivalent vaccines, leading to the development of SCTV01E, a tetravalent COVID-19 vaccine targeting variants Alpha, Beta, Delta, and Omicron BA.1.
  • A double-blind placebo-controlled trial showed SCTV01E had a vaccine efficacy of 69.4% against COVID-19 seven days post-vaccination, with higher efficacy rates in preventing symptomatic and all infections at 14 days.
  • The vaccine demonstrated a significant neutralizing antibody response against Omicron BA.5 and had mild reactogenicity, indicating its potential effectiveness against emerging SARS-CoV-2 variants.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists discovered that problems with phosphate (Pi) levels in the brain can cause brain calcification and worsen brain damage.
  • They found that certain genes, Pit2 and Xpr1, are really important for moving Pi in brain cells called astrocytes, which help control Pi levels.
  • By fixing the problems with these genes in mice, they were able to reduce brain calcification, suggesting that boosting how astrocytes handle Pi could be a good way to help treat brain issues.
View Article and Find Full Text PDF

Platelet-derived growth factor receptor α (PDGFRα) is often considered as a general marker of mesenchymal cells and fibroblasts, but also shows expression in a portion of osteoprogenitor cells. Within the skeleton, Pdgfrα+ mesenchymal cells have been identified in bone marrow and periosteum of long bones, where they play a crucial role in participating in fracture repair. A similar examination of Pdgfrα+ cells in calvarial bone healing has not been examined.

View Article and Find Full Text PDF
Article Synopsis
  • The mRNA-1345 vaccine has shown effectiveness against respiratory syncytial virus (RSV) in older adults (60+) during the ConquerRSV trial, with promising safety results.
  • In the trial, nearly 35,000 adults were randomly given either the mRNA-1345 vaccine or a placebo, and the immune response was measured 29 days after vaccination.
  • Findings revealed significant increases in neutralizing antibodies against RSV-A and RSV-B, confirming that the vaccine successfully boosts the immune response in older individuals, particularly those at higher risk of severe illness.
View Article and Find Full Text PDF

Professional phagocytes like neutrophils and macrophages tightly control what they consume, how much they consume, and when they move after cargo uptake. We show that plasma membrane abundance is a key arbiter of these cellular behaviors. Neutrophils and macrophages lacking the G protein subunit Gβ exhibited profound plasma membrane expansion, accompanied by marked reduction in plasma membrane tension.

View Article and Find Full Text PDF

Over 95% of pancreatic ductal adenocarcinomas (PDAC) harbor oncogenic mutations in K-Ras. Upon treatment with K-Ras inhibitors, PDAC cancer cells undergo metabolic reprogramming towards an oxidative phosphorylation-dependent, drug-resistant state. However, direct inhibition of complex I is poorly tolerated in patients due to on-target induction of peripheral neuropathy.

View Article and Find Full Text PDF
Article Synopsis
  • HPV 16 and 18 are linked to various cancers, and although preventative vaccines exist, there is a pressing need for therapeutic vaccines to treat existing HPV infections.
  • The study introduces a new mRNA-based therapeutic vaccine, mHTV-03E2, formulated in lipid nanoparticles, which effectively triggers strong immune responses in mice, resulting in reduced tumor growth and improved survival rates.
  • Moreover, mHTV-03E2 shows promise when used in combination with immune checkpoint inhibitors, enhancing its effectiveness in fighting cancers associated with HPV16 and HPV18 infections.
View Article and Find Full Text PDF

Immunotherapy with chimeric antigen receptor T cells for pediatric solid and brain tumors is constrained by available targetable antigens. Cancer-specific exons present a promising reservoir of targets; however, these have not been explored and validated systematically in a pan-cancer fashion. To identify cancer specific exon targets, here we analyze 1532 RNA-seq datasets from 16 types of pediatric solid and brain tumors for comparison with normal tissues using a newly developed workflow.

View Article and Find Full Text PDF

Objectives: To explore the potential of artificial intelligence (AI) to assist prescription determination for orthokeratology (OK) lenses.

Methods: Artificial intelligence algorithm development followed by a real-world trial. A total of 11,502 OK lenses fitting records collected from seven clinical environments covering major brands.

View Article and Find Full Text PDF

Intratumor heterogeneity (ITH) of bladder cancer (BLCA) contributes to therapy resistance and immune evasion affecting clinical prognosis. The molecular and cellular mechanisms contributing to BLCA ITH generation remain elusive. It is found that a TM4SF1-positive cancer subpopulation (TPCS) can generate ITH in BLCA, evidenced by integrative single cell atlas analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Biallelic loss of the gene encoding cyclin-dependent kinase 12 (CDK12) is linked to a distinct type of advanced prostate cancer, known as metastatic castration-resistant prostate cancer (mCRPC), though its role in cancer development and treatment response is still being investigated.
  • Research using mouse models shows that loss of CDK12 can lead to early-stage cancer changes and increased immune response, as well as promote tumor growth in lab settings when paired with other genetic modifications.
  • CDK12 mutations make tumors more responsive to certain immunotherapies and therapies targeting related kinases, suggesting that CDK12 acts as a tumor suppressor and emphasizing the potential for new treatment strategies focusing on related gene interactions in mutant m
View Article and Find Full Text PDF

Background: Air pollution particulate matter exposure and chronic cerebral hypoperfusion (CCH) contribute to white matter toxicity through shared mechanisms of neuroinflammation, oxidative stress, and myelin breakdown. Prior studies showed that exposure of mice to joint particulate matter and CCH caused supra-additive injury to corpus callosum white matter. This study examines the role of TLR4 (toll-like receptor 4) signaling in mediating neurotoxicity and myelin damage observed in joint particulate matter and CCH exposures.

View Article and Find Full Text PDF